ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2913

the Periodontal Pathogen Aggregatibacter Actinomycetemcomitans Is Associated with Subclinical Coronary Atherosclerosis in Rheumatoid Arthritis

Jon T. Giles1, Jesper Reinholdt2, Joan Bathon3, Felipe Andrade4 and Maximilian F. Konig5, 1Division of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, NY, 2Department of Biomedicine, Aarhus University, Aarhus, Denmark, 3Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 4Medicine/Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 5Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, pathogenesis and risk assessment, Periodontitis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 8, 2017

Title: Rheumatoid Arthritis – Clinical Aspects VI: Comorbidities of Rheumatoid Arthritis

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: The oral pathogen Aggregatibacter actinomycetemcomitans (Aa) generates citrullinated proteins targeted by autoantibodies in RA through its pore-forming toxin leukotoxin A (LtxA).  Aa-derived LtxA is implicated in atherogenesis and atherosclerotic plaque instability, conditions over-represented in RA.  No prior studies have explored the potential link between Aa, Aa-derived LtxA, and atherosclerosis in RA.

Methods: RA patients underwent cardiac computed tomography (CT) with coronary arterial calcification (CAC), a measure of coronary atherosclerosis, assessed.  Serum levels of IgG antibodies against Aa serotype b and purified LtxA were measured by ELISA.  Healthy controls cutoffs for seropositivity were used.   Multivariable robust regression was used to model the associations of anti-Aa and anti-LtxA with CAC, adjusting for pertinent confounders.

Results: A total of 194 RA patients [mean age=59 years; 60% female: median RA duration=9 years; 79% RF or anti-CCP seropositive] were studied.  Anti-Aa was detected in n=41 (21%) and anti-LtxA in n=82 (42%).  Adjusting for relevant confounders (listed in Fig), those with anti-LtxA had a mean CAC score 65% higher than those without anti-Aa or anti-LtxA (61 vs. 37 units, respectively; p=0.005 (Fig1a)].  Those anti-Aa+/anti-LtxA– had a mean adjusted CAC score 262% higher than those with neither antibody (134 vs. 37 units, respectively; p<0.001) and 120% higher than those with anti-LtxA, with or without concomitant anti-Aa.  Among CAC-associated features, swollen joint count (SJC) was differentially associated with CAC depending on the context of anti-LtxA.   In anti-LtxA– patients, SJC was not associated with CAC (Figure 1B, open circles).  However, in anti-LtxA+ patients, each swollen joint was associated, on average, with a 6 unit higher CAC score (p<0.001).  The interaction of anti-LtxA and swollen joints was significant (p=0.002).  The association was not linear, with a marked difference noted in those with>10 swollen joints (Figure 1B, solid diamonds).  Combining the two above groups with higher CAC scores [i.e. anti-Aa+/anti-LtxA– and anti-LtxA+ and>10 swollen joints; n=32 (16% of the cohort)], the adjusted mean CAC was 171% higher vs. those without these features (114 vs. 42 units, respectively; p<0.001).

Conclusion: Infection with the periodontal pathogen Aa may contribute to atherosclerosis in RA. Anti-LtxA, a marker of exposure to leukotoxic Aa strains, was significantly associated with more CAC and identified patients in which synovitis was robustly and independently associated with the extent of CAC.  A subgroup of RA patients with isolated antibody positivity to the leukotoxic Aa serotype b showed markedly higher risk of atherosclerosis. Additional studies are warranted to elucidate the underlying mechanism, and whether Aa-specific screening and treatment may reduce CVD risk in RA patients.


Disclosure: J. T. Giles, None; J. Reinholdt, None; J. Bathon, None; F. Andrade, None; M. F. Konig, None.

To cite this abstract in AMA style:

Giles JT, Reinholdt J, Bathon J, Andrade F, Konig MF. the Periodontal Pathogen Aggregatibacter Actinomycetemcomitans Is Associated with Subclinical Coronary Atherosclerosis in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-periodontal-pathogen-aggregatibacter-actinomycetemcomitans-is-associated-with-subclinical-coronary-atherosclerosis-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-periodontal-pathogen-aggregatibacter-actinomycetemcomitans-is-associated-with-subclinical-coronary-atherosclerosis-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology